Poseida Therapeutics Banner Image

Poseida Therapeutics

  • Ticker PSTX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Poseida Therapeutics Logo Image
  • 201-500 Employees
  • Based in San Diego, California
Poseida Therapeutics is a clinical-stage biopharmaceutical company advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases. The Company’s pipeline includes allogeneic CAR-T cell therapy product candidates for both solid and liquid tumors as well as in vivo gene therapy product candidates that address patient populations with high unmetMore medical need. Poseida’s approach to cell and gene therapies is based on its proprietary genetic editing platforms, including its non-viral Super piggyBac® DNA Delivery System, Cas-CLOVER™ Site-Specific Gene Editing System and nanoparticle and hybrid gene delivery technologies. The Company has formed global strategic collaborations with Roche and Takeda to unlock the promise of cell and gene therapies for patients.
3.0 / 5.0 (1)

Poseida Therapeutics reports have an aggregate usefulness score of 3.0 based on 1 reviews.

Poseida Therapeutics

Most Recent Annual Report

Poseida Therapeutics
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Poseida Therapeutics Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!